Alembic Pharmaceuticals Ltd Share Holding Pattern

Home

Insights

Share Holding

₹ 0.4 Cr

Volume Transacted

(Nov 22, 2024)

3.7 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Promoters Holdings Over Time

Key Highlights

Mutual funds increased their stake in the company by 0.23% from March 2024 to June 2024.
FIIs/FPIs decreased their stake in the company by 0.14% from March 2024 to June 2024.

Latest Shareholding

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Market Price of Alembic Pharmaceuticals Ltd

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date	Price (₹)	Day Open (₹)	Day High (₹)	Day Low (₹)

22 Nov 2024	1041.8	1032.95	1047.9	1028.85
21 Nov 2024	1038.2	1022.3	1042.25	1020.85
19 Nov 2024	1042.6	1029.95	1050.4	1029.95
18 Nov 2024	1024.15	1017	1027.9	993.15
14 Nov 2024	1029.8	1020.8	1035.45	1017.45
13 Nov 2024	1018.9	1048	1048	1001.95
12 Nov 2024	1029.25	1035.5	1044.7	1018.5
11 Nov 2024	1030.95	1039	1064.15	1011.05
08 Nov 2024	1039	1080.1	1093.45	1031.75
07 Nov 2024	1081.45	1118	1152.6	1072.6

Date	Price (₹)
22 Nov 2024	1041.8
21 Nov 2024	1038.2
19 Nov 2024	1042.6
18 Nov 2024	1024.15
14 Nov 2024	1029.8
13 Nov 2024	1018.9
12 Nov 2024	1029.25
11 Nov 2024	1030.95
08 Nov 2024	1039
07 Nov 2024	1081.45

Alembic Pharmaceuticals Ltd News Hub

Alembic Pharmaceuticals receives USFDA approval for Ivabradine Tablets

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

12 Nov 202414:59

Alembic Pharmaceuticals receives USFDA approval for Diltiazem Hydrochloride ER capsules

Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the U...

11 Nov 202409:03

Alembic Pharma gets US FDA nod for Diltiazem Hydrochloride ER capsules

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

11 Nov 202409:47

Alembic Pharma gets USFDA nod for hypertension treatment drug

The said drug is therapeutically equivalent to the reference listed drug product (RLD), Di...

21 Oct 202411:23

Alembic Pharmaceuticals to discuss results

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 ...

18 Oct 202417:20

Alembic Pharma's oncology formulations unit successfully completes USFDA inspection

Alembic Pharmaceuticals has successfully completed the United States Food and Drug Adminis...

09 Oct 202409:16

Document

Annual Reports

Annual Report 2024

Credit Ratings

Credit Report 2024

Concalls

May 2024

Feb 2024

Nov 2023

Aug 2023

May 2023

Feb 2023

Nov 2022

Aug 2022

May 2022

Feb 2022

Nov 2021

Aug 2021

May 2021

May 2024

Feb 2024

Nov 2023

Aug 2023

May 2023

Feb 2023

Nov 2022

Aug 2022

May 2022

Feb 2022

Nov 2021

Aug 2021

May 2021

Popular Search

Alembic Pharmaceuticals Ltd pe ratio

Alembic Pharmaceuticals Ltd eps

Alembic Pharmaceuticals Ltd share price history

Alembic Pharmaceuticals Ltd dividend

Alembic Pharmaceuticals Ltd market cap

Alembic Pharmaceuticals Ltd pb ratio

Sun Pharmaceuticals Industries Ltd share holding pattern

Divis Laboratories Ltd share holding pattern

Cipla Ltd share holding pattern

Torrent Pharmaceuticals Ltd share holding pattern

Mankind Pharma Ltd share holding pattern

Dr Reddys Laboratories Ltd share holding pattern

Zydus Lifesciences Ltd share holding pattern

Lupin Ltd share holding pattern

Aurobindo Pharma Ltd share holding pattern

Alkem Laboratories Ltd share holding pattern

FAQs for EPS of Alembic Pharmaceuticals Ltd

On what factors does the shareholding pattern of Alembic Pharmaceuticals Ltd change frequently?

The shareholding pattern of Alembic Pharmaceuticals Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.

How often is Alembic Pharmaceuticals Ltd's shareholding pattern updated?

The Alembic Pharmaceuticals Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.

What categories are included in the shareholding pattern of Alembic Pharmaceuticals Ltd?

Categories included in the shareholding pattern of Alembic Pharmaceuticals Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.

Why is the shareholding pattern of Alembic Pharmaceuticals Ltd important for investors?

The shareholding pattern of Alembic Pharmaceuticals Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.

Where can I find the latest shareholding pattern of Alembic Pharmaceuticals Ltd?

The latest shareholding pattern of Alembic Pharmaceuticals Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*